VCYT: Veracyte, Inc. Company Profile & Statistics

Veracyte, Inc. Profile

About

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.

Info & Links

CEO

Marc Stapley

Headquarters

6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

824

Veracyte, Inc. Statistics

Valuation Measures

Market Capitalization²

2.81B

Enterprise Value

2.59B

Enterprise Value/EBITDA(ttm)

70.45

Price to Earnings Ratio(ttm)

39.22

Price to Sales(ttm)

5.92

Price to Book(mrq)

2.31

Price to Cash(ytd)

34.80

Profitability

Gross Margin(ttm)

68.25%

Operating Margin(ttm)

15.10%

Profit Margin(ttm)

5.70%

Return on Equity(ttm)

6.07%

Return on Invested Capital(ttm)

2.23%

Return on Assets(ttm)

5.53%

Income Statement

Revenue(ttm)

479.13M

Revenue Per Share(ttm)

6.09

Gross Profit(ttm)

327.04M

EBITDA(ttm)³

36.81M

Net Income Available to Common(ttm)

26.34M

Diluted EPS(ttm)

0.33

Share Statistics

Beta (5Y Monthly)

2.16

52-Week Change

4.21%

S&P 500 52-Week Change

19.86%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

78.67M

Dividend Yield

0.00%

Float⁴

77.57M

% Held by Insiders

1.40%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

320.72M

Total Cash Per Share(mrq)

4.08

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.43%

Quick Ratio(mrq)

5.10%

Book Value Per Share(mrq)

15.54

Cash Flow

Operating Cash Flow Per Share(ytd)

0.50

Free Cash Flow(ytd)

35.86M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VCYT

Veracyte, Inc.